Shanton, Receives

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Shanton Pharma Denmark Finland France Germany Netherlands Sweden United Kingdom New Jersey Singapore

View original content:https://www.prnewswire.co.uk/news-releases/shanton-receives-fast-track-designation-from-us-fda-for-refractory-gout-program-302514010.html

en | boerse | 67950713 |